In summary, our study is the first comprehensive, detailed and systematic meta-analysis evaluating and demonstrating the diagnostic and prognostic value of FOXO3 in HCC, thus covering an unexplored research pathway. This evidence concerns the gene FOXO3 and hepatocellular carcinoma.